If you need more lookups,
subscriptions start at $34 USD/month.
Su Choi Location
Gaithersburg, MD, US
Su Choi Work
Associate Director @ (October 2023 - Present)
Associate Principal Scientist @ (July 2022 - September 2023)
Senior Scientist @ (June 2020 - June 2022)
Scientist I @ (September 2018 - May 2020)
Sr. Research Specialist @ (June 2016 - September 2018)
Research Associate @ (August 2014 - May 2016)
Post-Doctoral Fellow @ (August 2009 - July 2014)
Research Professor and Instructor @ (March 2008 - July 2009)
Su Choi Education
서울시립대학교 (University of Seoul)
Doctor of Philosophy (Ph.D.) (Biochemistry and Molecular Biology)
2004-2008
Su Choi Skills
Assay Development
Business Development
Cancer Biology
Cell
Cell Biology
Cell Culture
Cell Therapy
Cellular Communications
Chromatin Immunoprecipitation
Cross-functional Team Leadership
Data Analysis
Differentiation
Drug Discovery
ELISA
EMSA
Embryonic Stem Cells
Flow Cytometry
Fluorescence Microscopy
Hypoxia
Immunofluorescence
Immunohistochemistry
Immunoprecipitation
Immunotherapy
Induced Pluripotent Stem Cells
Lab management
Liver Disease
Metabolism
Microarray Analysis
Molecular Biology
Molecular Cloning
New Technology Evaluation
Northern Blotting
PCR
Peer Reviews
People Management
Pre-clinical Studies
Primary Cell Isolation
Processes Development
Project Management
Protein Expression
Protein Purification
RNAi
Regenerative Medicine
Stem Cell Differentiation
Stem Cell Research
Stem Cell Technology
Western Blotting
Yeast two-hybrid
qRT-PCR
Su Choi Summary
Su Choi, based in Gaithersburg, MD, US, is currently a Associate Director at AstraZeneca. Su Choi brings experience from previous roles at AstraZeneca and The Johns Hopkins University. Su Choi holds a 2004 - 2008 Doctor of Philosophy (Ph.D.) in Biochemistry and Molecular Biology @ 서울시립대학교 (University of Seoul). With a robust skill set that includes Assay Development, Business Development, Cancer Biology, Cell, Cell Biology and more. Su Choi has 2 emails on RocketReach.
Looking for a different Su Choi?
Find contact details for 700 million professionals.